4//SEC Filing
STROMATT SCOTT 4
Accession 0000891293-06-000013
CIK 0000891293other
Filed
Jun 21, 8:00 PM ET
Accepted
Jun 22, 6:38 PM ET
Size
6.7 KB
Accession
0000891293-06-000013
Insider Transaction Report
Form 4
STROMATT SCOTT
EVP, Clinical Dev & Reg Affair
Transactions
- Sale
Common Stock
2006-06-20$1.40/sh−10,000$14,000→ 65,000 total
Footnotes (1)
- [F1]The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan. Proceeds from the sale were used to cover taxes related to the vesting of restricted stock on June 16, 2006.
Documents
Issuer
CELL THERAPEUTICS INC
CIK 0000891293
Entity typeother
Related Parties
1- filerCIK 0001187053
Filing Metadata
- Form type
- 4
- Filed
- Jun 21, 8:00 PM ET
- Accepted
- Jun 22, 6:38 PM ET
- Size
- 6.7 KB